KalVista Pharmaceuticals (KALV) Short Interest Ratio & Short Volume $11.42 -0.45 (-3.79%) Closing price 05/22/2025 04:00 PM EasternExtended Trading$11.56 +0.14 (+1.26%) As of 09:06 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock KalVista Pharmaceuticals Short Interest DataKalVista Pharmaceuticals (KALV) has a short interest of 5.86 million shares. This marks a -5.64% decrease in short interest from the previous month. The short interest ratio (days to cover) is 9.9, indicating that it would take 9.9 days of the average trading volume of 420,654 shares to cover all short positions.Current Short Interest5,860,000 sharesPrevious Short Interest6,210,000 sharesChange Vs. Previous Month-5.64%Dollar Volume Sold Short$80.69 millionShort Interest Ratio9.9 Days to CoverLast Record DateApril 30, 2025Outstanding Shares49,716,000 sharesPercentage of Shares Shorted11.79%Today's Trading Volume549,287 sharesAverage Trading Volume420,654 sharesToday's Volume Vs. Average131% Short Selling KalVista Pharmaceuticals? Sign up to receive the latest short interest report for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartKALV Short Interest Over TimeKALV Days to Cover Over TimeKALV Percentage of Float Shorted Over Time KalVista Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20255,860,000 shares $80.69 million -5.6%N/A9.9 $13.77 4/15/20256,210,000 shares $74.64 million +6.0%14.0%11.2 $12.02 3/31/20255,860,000 shares $67.62 million +0.3%13.2%11.2 $11.54 3/15/20255,840,000 shares $73.58 million +5.4%13.2%12.9 $12.60 2/28/20255,540,000 shares $63.16 million -5.0%12.5%13.3 $11.40 2/15/20255,830,000 shares $56.90 million -18.2%13.2%15.7 $9.76 1/31/20257,130,000 shares $63.53 million -6.1%N/A19.3 $8.91 1/15/20257,590,000 shares $59.66 million +1.9%N/A21 $7.86 12/31/20247,450,000 shares $63.10 million +3.8%N/A21.5 $8.47 12/15/20247,180,000 shares $62.39 million -1.1%N/A17.8 $8.69 Get the Latest News and Ratings for KALV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/30/20247,260,000 shares $73.04 million -1.5%N/A17.6 $10.06 11/15/20247,370,000 shares $69.94 million +7.3%N/A17.7 $9.49 10/31/20246,870,000 shares $70.55 million +0.9%N/A19 $10.27 10/15/20246,810,000 shares $81.58 million +4.6%N/A20.1 $11.98 9/30/20246,510,000 shares $75.39 million +13.8%N/A17 $11.58 9/15/20245,720,000 shares $63.72 million +1.2%N/A15.6 $11.14 8/31/20245,650,000 shares $75.65 million -0.5%N/A17.4 $13.39 8/15/20245,680,000 shares $72.65 million -5.0%N/A17.9 $12.79 7/31/20245,980,000 shares $86.95 million -5.5%N/A18.3 $14.54 7/15/20246,330,000 shares $94.70 million +7.7%N/A18.4 $14.96 6/30/20245,880,000 shares $69.27 million +4.3%N/A17.7 $11.78 6/15/20245,640,000 shares $68.07 million +2.2%N/A15.4 $12.07 5/31/20245,520,000 shares $64.42 million -4.2%N/A14.1 $11.67 5/15/20245,760,000 shares $69.18 million +4.0%N/A11.7 $12.01 4/30/20245,540,000 shares $62.88 million -4.8%N/A7.4 $11.35 4/15/20245,820,000 shares $68.33 million +5.4%N/A7.3 $11.74 3/31/20245,520,000 shares $65.47 million +12.2%N/A6.8 $11.86 3/15/20244,920,000 shares $58.70 million +9.1%N/A6.4 $11.93 2/29/20244,510,000 shares $61.56 million +50.8%18.6%5.9 $13.65 2/15/20242,990,000 shares $44.13 million +21.1%12.4%4.4 $14.76 1/31/20242,470,000 shares $38.95 million -10.5%12.9%6.1 $15.77 1/15/20242,760,000 shares $35.77 million -25.2%14.2%8.3 $12.96 12/31/20233,690,000 shares $45.20 million +5.7%18.7%11.8 $12.25 12/15/20233,490,000 shares $37.27 million -9.6%16.7%10.8 $10.68 11/30/20233,860,000 shares $32.58 million -3.5%18.2%13.4 $8.44 11/15/20234,000,000 shares $30.76 million -3.4%19.0%13.9 $7.69 10/31/20234,140,000 shares $35.15 million -10.8%17.3%14.8 $8.49 10/15/20234,640,000 shares $42.13 million +4.7%N/A16.9 $9.08 9/30/20234,430,000 shares $42.66 million +9.1%N/A16.9 $9.63 9/15/20234,060,000 shares $39.87 million +4.6%N/A19.4 $9.82Watch This Robotics Demo Before July 23rd (Ad)Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo… 8/31/20233,880,000 shares $42.10 million -5.4%N/A19.1 $10.85 8/15/20234,100,000 shares $44.32 million +2.8%19.7%21.4 $10.81 7/31/20233,990,000 shares $40.30 million +2.3%18.3%21 $10.10 7/15/20233,900,000 shares $37.60 million +3.7%17.9%21 $9.64 6/30/20233,760,000 shares $33.84 million +0.8%17.3%18.5 $9.00 6/15/20233,730,000 shares $35.92 million +3.9%17.2%17.2 $9.63 5/31/20233,590,000 shares $35.00 million +5.0%16.5%14.6 $9.75 5/15/20233,420,000 shares $34.58 million +4.3%15.8%12.6 $10.11 4/30/20233,280,000 shares $27.98 million +17.1%14.0%11.5 $8.53 4/15/20232,800,000 shares $22.15 million +3.3%12.0%8.7 $7.91 3/31/20232,710,000 shares $21.30 million +10.2%11.6%8 $7.86 3/15/20232,460,000 shares $18.33 million +13.4%N/A7 $7.45 2/28/20232,170,000 shares $15.91 million -19.6%N/A6.3 $7.33 2/15/20232,700,000 shares $20.87 million -0.4%N/A8.6 $7.73 1/31/20232,710,000 shares $21.57 million +26.6%N/A8.9 $7.96 1/15/20232,140,000 shares $15.19 million -10.5%N/A6.7 $7.10 12/30/20222,390,000 shares $16.16 million +14.9%10.2%7.4 $6.76 12/15/20222,080,000 shares $11.90 million No Change10.4%4.7 $5.72 11/30/20222,080,000 shares $11.21 million No Change10.4%5.1 $5.39 11/15/20222,080,000 shares $10.86 million -8.8%10.4%5.1 $5.22 10/31/20222,280,000 shares $11.56 million -0.4%10.9%5.5 $5.07 10/15/20222,290,000 shares $10.44 million -10.2%10.9%6.2 $4.56 9/30/20222,550,000 shares $37.00 million +3.7%12.2%7.7 $14.51 9/15/20222,460,000 shares $36.43 million +4.7%11.8%13.2 $14.81 8/31/20222,350,000 shares $38.70 million +14.6%11.2%10.7 $16.47 8/15/20222,050,000 shares $32.41 million +8.5%9.8%7.3 $15.81 7/31/20221,890,000 shares $23.34 million +2.7%9.0%6.1 $12.35 7/15/20221,840,000 shares $22.69 million +3.4%8.7%5.7 $12.33 6/30/20221,780,000 shares $17.52 million -16.8%8.5%5.3 $9.84 6/15/20222,140,000 shares $19.07 million +58.5%10.2%6.4 $8.91 5/31/20221,350,000 shares $12.00 million +7.1%6.4%4.6 $8.89 5/15/20221,260,000 shares $12.23 million +37.7%6.0%5.4 $9.71 4/30/2022914,800 shares $11.65 million +4.6%4.3%4.4 $12.73 4/15/2022874,800 shares $12.56 million -19.7%4.2%4.2 $14.36 3/31/20221,090,000 shares $16.07 million -17.4%5.2%5.2 $14.74 3/15/20221,320,000 shares $19.14 million +1.5%6.3%6.6 $14.50 2/28/20221,300,000 shares $20.87 million +13.0%6.2%6.3 $16.05 2/15/20221,150,000 shares $18.95 million -5.7%5.5%5 $16.48 1/31/20221,220,000 shares $15.40 million +15.1%5.8%5.7 $12.62 1/15/20221,060,000 shares $13.29 million +11.9%5.0%5 $12.54 12/31/2021947,400 shares $12.53 million +0.4%4.5%4.7 $13.23 12/15/2021943,800 shares $12.81 million -2.2%4.2%4.4 $13.57 11/30/2021964,800 shares $13.99 million -6.3%4.3%4.4 $14.50 11/15/20211,030,000 shares $17.94 million -5.5%4.6%5.4 $17.42 10/29/20211,090,000 shares $19.60 million -11.4%4.9%5.8 $17.98 10/15/20211,230,000 shares $21.17 million +3.4%5.5%6.9 $17.21 9/30/20211,190,000 shares $20.77 million -14.4%5.4%6.5 $17.45 9/15/20211,390,000 shares $26.76 million -21.0%6.2%7 $19.25 8/31/20211,760,000 shares $35.97 million -4.9%7.9%8.7 $20.44 8/13/20211,850,000 shares $35.72 million -4.2%8.3%8.6 $19.31Watch This Robotics Demo Before July 23rd (Ad)Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo… 7/30/20211,930,000 shares $38.87 million -1.5%9.5%8.5 $20.14 7/15/20211,960,000 shares $43.04 million -2.0%9.9%7.7 $21.96 6/30/20212,000,000 shares $47.92 million +39.9%10.1%6.7 $23.96 6/15/20211,430,000 shares $40.78 million +3.6%7.2%4.6 $28.52 5/28/20211,380,000 shares $37.26 million -3.5%7.0%4.2 $27.00 5/14/20211,430,000 shares $35.91 million +6.7%N/A3.9 $25.11 4/30/20211,340,000 shares $33.81 million +3.1%N/A1.2 $25.23 4/15/20211,300,000 shares $32.40 million +10.2%N/A1.2 $24.92 3/31/20211,180,000 shares $30.33 million +51.8%N/A1.2 $25.70 3/15/2021777,400 shares $25.27 million -0.6%N/A0.8 $32.50 2/26/2021782,400 shares $25.99 million +22.0%N/A0.9 $33.22 2/12/2021641,100 shares $25.93 million +25.0%3.8%0.7 $40.45 1/29/2021513,100 shares $8.02 million +28.2%4.5%0.8 $15.64 1/15/2021400,200 shares $6.88 million +4.7%3.5%3.3 $17.18 12/31/2020382,400 shares $7.22 million +27.3%3.4%3.2 $18.89 12/15/2020300,300 shares $5.69 million -11.6%2.7%3 $18.95 11/30/2020339,700 shares $6.61 million +3.9%3.0%3.8 $19.47 11/15/2020326,900 shares $6.15 million +47.0%2.8%3.8 $18.80 10/30/2020222,400 shares $3.83 million -12.3%1.9%2.9 $17.22 10/15/2020253,600 shares $3.79 million +2.3%2.2%3.7 $14.95 9/30/2020247,900 shares $3.12 million -16.4%2.1%3.8 $12.59 9/15/2020296,600 shares $4.12 million -7.1%2.5%3.4 $13.88 8/31/2020319,100 shares $4.18 million -10.6%2.7%2.6 $13.10 8/14/2020356,900 shares $4.53 million -9.2%2.8%2.8 $12.70 7/31/2020392,900 shares $3.86 million -8.7%3.1%2.9 $9.83 7/15/2020430,200 shares $4.97 million +9.8%3.4%3.2 $11.56 6/30/2020391,800 shares $4.74 million +24.2%3.1%2.8 $12.10 6/15/2020315,500 shares $3.28 million -7.5%2.5%2.3 $10.40 5/29/2020341,200 shares $3.71 million +1.2%2.7%2.6 $10.86 KALV Short Interest - Frequently Asked Questions What is KalVista Pharmaceuticals' current short interest? Short interest is the volume of KalVista Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 5,860,000 shares of KALV short. Learn More on KalVista Pharmaceuticals' current short interest. What is a good short interest ratio for KalVista Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KALV shares currently have a short interest ratio of 10.0. Learn More on KalVista Pharmaceuticals's short interest ratio. Is KalVista Pharmaceuticals' short interest increasing or decreasing? KalVista Pharmaceuticals saw a decline in short interest in April. As of April 30th, there was short interest totaling 5,860,000 shares, a decline of 5.6% from the previous total of 6,210,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does KalVista Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to KalVista Pharmaceuticals: Xenon Pharmaceuticals Inc. (4.67%), Amneal Pharmaceuticals, Inc. (4.44%), HUTCHMED (China) Limited (0.24%), Organon & Co. (7.61%), Mirum Pharmaceuticals, Inc. (12.58%), Apellis Pharmaceuticals, Inc. (22.89%), Arrowhead Pharmaceuticals, Inc. (9.80%), Vericel Co. (9.18%), NewAmsterdam Pharma (8.68%), Belite Bio, Inc (0.23%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short KalVista Pharmaceuticals stock? Short selling KALV is an investing strategy that aims to generate trading profit from KalVista Pharmaceuticals as its price is falling. KALV shares are trading down $0.45 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against KalVista Pharmaceuticals? A short squeeze for KalVista Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KALV, which in turn drives the price of the stock up even further. How often is KalVista Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KALV, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies XENE Short Squeeze AMRX Short Squeeze HCM Short Squeeze OGN Short Squeeze MIRM Short Squeeze APLS Short Squeeze ARWR Short Squeeze VCEL Short Squeeze NAMS Short Squeeze BLTE Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KALV) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KalVista Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share KalVista Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KALV Stock Free KALV Stock Alerts